Back to News
Market Impact: 0.25

Guru Fundamental Report for CRM

CRMNDAQ
Company FundamentalsAnalyst InsightsTechnology & Innovation
Guru Fundamental Report for CRM

Validea's guru fundamental report rated Salesforce (CRM) at 66% using Partha Mohanram's P/B Growth Investor model, which seeks sustainable growth in low book-to-market stocks. While the large-cap software firm passed key financial health metrics such as return on assets and cash flow from operations, it failed criteria related to advertising, capital expenditures, and R&D relative to assets, indicating it does not meet the 80% threshold for significant interest by this outperforming growth strategy.

Analysis

Salesforce Inc. (CRM) received a moderate 66% rating based on Validea's P/B Growth Investor model, which is derived from Partha Mohanram's academic research on identifying sustainable growth stocks. This score is notably below the 80% threshold that the strategy considers a signal of interest. The analysis indicates a mixed fundamental picture for the large-cap software firm. On the positive side, CRM passed crucial tests related to its low book-to-market ratio, return on assets (ROA), cash flow from operations to assets, and the stability of its ROA and sales variance. These passes suggest underlying financial health and operational consistency. However, the model flagged significant weaknesses, as CRM failed criteria measuring advertising, capital expenditures, and research and development as a percentage of assets. These failures imply that, from the perspective of this specific quantitative model, the company's allocation of capital towards key growth drivers may not be optimized for long-term outperformance.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.15

Ticker Sentiment

CRM0.15
NDAQ0.00

Key Decisions for Investors

  • Investors should recognize that while Salesforce exhibits core financial health, its 66% score on the Mohanram growth model indicates it does not fit the profile of a top-tier growth stock according to this specific, historically successful quantitative screen.
  • The failure on metrics related to R&D, advertising, and capital expenditures warrants a deeper investigation into the efficiency and return on these investments, as they are critical for a technology company's future growth trajectory.
  • For portfolios that rely on quantitative growth strategies, this report serves as a cautionary signal, suggesting that CRM may not deliver the type of sustained growth that models like Mohanram's are designed to capture, despite its stable operational metrics.